GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 56 filers reported holding GT BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $277,438 | +5.8% | 1,087,993 | +0.1% | 0.00% | – |
| Q3 2023 | $262,132 | -23.6% | 1,087,234 | -1.1% | 0.00% | – |
| Q2 2023 | $342,999 | -44.7% | 1,099,354 | -2.5% | 0.00% | – |
| Q1 2023 | $620,073 | -37.9% | 1,127,405 | 0.0% | 0.00% | – |
| Q4 2022 | $998,543 | -49.6% | 1,127,405 | +0.0% | 0.00% | – |
| Q3 2022 | $1,983,000 | -41.1% | 1,126,941 | +0.0% | 0.00% | – |
| Q2 2022 | $3,369,000 | +18.4% | 1,126,841 | +14.1% | 0.00% | – |
| Q1 2022 | $2,845,000 | -22.7% | 987,942 | -18.1% | 0.00% | – |
| Q4 2021 | $3,680,000 | -43.3% | 1,206,352 | +25.2% | 0.00% | – |
| Q3 2021 | $6,493,000 | -57.4% | 963,323 | -1.9% | 0.00% | – |
| Q2 2021 | $15,225,000 | +731.5% | 982,269 | +267.0% | 0.00% | – |
| Q1 2021 | $1,831,000 | – | 267,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moss Adams Wealth Advisors LLC | 20,000 | $5,100 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300,719 | $76,683 | 0.00% |
| JANE STREET GROUP, LLC | 19,405 | $4,948 | 0.00% |
| NORTHERN TRUST CORP | 32,347 | $8,248 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 14,605 | $3,724 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,017 | $258 | 0.00% |
| Retirement Group, LLC | 44 | $11 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 337,315 | $86,046 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 65,953 | $16,818 | 0.00% |